3rd Microbiome Drug Development Summit
29th Jan - 30th Jan 2019 | Bagnolet, France
Helping large pharma, biotech and academic institutions accelerate the discovery, clinical development of safe, effective and commercially scalable microbiome therapeutics across a broad range of disease indications.
View the agenda here.
Pre-arrange to meet with Cobra’s Sales and Marketing Director, Philip Ridley-Smith (pictured) and Scientific Lead in PDPM, Mikael Dahl, using the simple form below: